INTRODUCTION TELOMERE LENGTH REGULATION
Telomeres are regions at the ends of chromosomes containing 1-5kb of (TTAGGG) repeats which protects DNA against degradation and recombination, thus supporting chromosomal stability (20) . In most somatic cells telomeres shorten with every cell cycle because of the difficulty in priming DNA synthesis by DNA polymerase in this region. Telomere length therefore reflects the length at birth and its rate of attrition thereafter. The latter is as a result of replication history, but also a reflection of a number of factors, such as cumulative oxidative stress and chronic inflammation (21) , acting on progenitor cells (see below). Abnormalities in TL have been described both in COPD and IPF.
In circulating leukocytes, current and former smokers had shorter telomeres than did age-matched nonsmokers (22) , there is a dose-dependent relationship between TL and the years smoked (23) and TL in COPD patients is shorter than that of control subjects in any age range (24). Other studies have shown shorter telomeres in the lungs of COPD patients, particularly those with emphysema (25, 26). Experimental animals with shorter telomeres in their lung cells have an increased susceptibility to cigarette smoke-induced emphysema (27).
In patients with IPF, short telomeres in lung epithelial cells and peripheral blood cells have also been identified(28, 29). Interestingly,10% of patients with familial pulmonary fibrosis (FPF) have mutations of one of the two key factors involved in telomere lengthening: the reverse transcriptase component (TERT) and the RNA template component (TERC)(30). In addition, around 20% of patients with dyskeratosis congenita, a genetic disease caused by telomerase mutations, develop pulmonary fibrosis (31).
CELLULAR SENESCENCE
When TL reaches a critical value, a "DNA damage response" is activated, leading to cell-cycle arrest (senescence) and, eventually, apoptosis. Cell senescence is, therefore, the cellular equivalent of aging. A number of cellular and molecular mechanisms are associated with cell senescence, including: (a) persistence of active metabolism, loss of proliferative activity and resistance to apoptosis; (b)accumulation of DNA damage, impairment of DNA repair, epigenetic modifications of nuclear DNA and attrition of telomeres; and, (c)protein, nucleic acids and lipids damage from oxidative stress(32, 33). As a result, senescent cells enter an irreversible growth arrest, exhibit flattened and enlarged morphology and expresses a different set of genes, including the cell cycle control kinase inhibitors p53, p21 and p16(34). Cellular senescence and cell arrest can occur by intrinsic and extrinsic mechanisms. The former relate to the exhaustion of a predetermined proliferative capacity with erosion of telomeres (replicative senescence); the latter to the effect of external stresses, such as oxidative stress (stress-induced premature senescence).Cell senescence has been identified both in COPD and IPF.
In vitro exposure of human epithelial cells to cigarette smoke, the major etiological factor in COPD, results in changes in cell morphology indicative of cellular senescence, such as increased expression of senescence-associated ß-galactosidase (SA-ß-gal) and elevated p21 CIP1/WAP1/sdi1 protein (35) .Similar increased expression of markers of cellular senescence were found in Type II alveolar epithelial cells in the lungs of mice exposed for three weeks to cigarette smoke associated with the accumulation of lipofuscin, indicating that stressinduced premature senescence had occurred (35) .Likewise, increased markers of cellular senescence are also present in emphysematous lungs. For instance, the expression of the senescent associated markers p16
INK4a and p21 CIP1/WAP1/sdi1 are higher in Type II alveolar epithelial cells in the lungs of patients with emphysema than in control smokers and non-smokers (36) .
Cellular senescence can contribute to the pathogenesis of COPD through at least two, non-mutually exclusive, mechanisms. First, increased epithelial and endothelial cell apoptosis occurs in emphysematous lungs (37, 38) . This is Interestingly, senescent B-MSC increase the susceptibility to the development of fibrosis because of abnormal repair responses triggered in subjects exposed to tobacco, asbestos, and other agents known to stimulate DNA damage (56). (Table 1) .
ANTI-AGING MOLECULES

Innate immune response and aging
Age related changes of the innate immune response involve both gain and loss of function in different cell types (75, 76) . In general, the former are characterized by the presence of a persistent, low-grade pro-inflammatory environment, as shown by elevated levels of IL-6, TNF-α and acute phase reactants (inflammaging) (77) , whereas the latter includes decreased functionality of specific innate immune effectors (75 (84) 
Acquired immune response and aging
The acquired immune response also changes with age, including a reduction in the production of lymphocytes by primary lymphoid organs and modifications lymphoid cell diversity and functionality (74, 96) 
EXTRACELLULAR MATRIX (ECM) CHANGES INDUCED BY AGING
Collagen and elastin are the main proteins in the ECM that make up the framework of the alveolar structure, and are most important in determining the mechanical properties of lung parenchyma. In the lung, collagen represents 15 to 20% of the total dry weight of the pulmonary tissue; type I and III collagens (COL I to COL III, respectively) are the most representative of these, representing 90% of the total collagen. Another protein, fibronectin, forms fibrils associated with other matrix components and it has been implicated in cell adhesion, migration, epithelial-mesenchymal transition (EMT), phagocytosis, and cell growth.
The composition of the ECM changes during aging (103) Hence, their relevance for the pathogenesis of COPD is unclear but they can clearly contribute to explain, at least in part, the increased incidence of interstitial fibrotic lung disorders in elderly populations. As a corollary, we propose that the ageing process is abnormal rather than accelerated in these patients, since these two diseases appear to be the result of defective and/or exhausted mechanisms of repair rather than their shift (accelerated aging) with early accumulations of these defects. In any case, a better understanding of these abnormalities may help designing novel and better therapeutic alternatives for patients suffering these devastating diseases. decrease on their ability to repair damaged organs. These observations are providing novel mechanisms to account for the higher incidence of chronic fibrosing lung disorders in subjects exposed to tobacco, asbestos, and other agents known to stimulate DNA damage. (43, 44, 110, 111) .
CONCLUSIONS
Anti aging molecules
The expression of Klotho in CD4+ lymphocytes decreases with age (112).
Knock-out mice models of SMP30 and Klotho develop accelerated aging and emphysema (57).
Decreased levels of SIRT-1, HDAC2 are found in the lung of COPD patients (65) . Inflammatory cytokines Persistent low level inflammation: IL-6, TNF-α and acute phase reactants (77) .
Systemic and pulmonary increased levels of IL-6, TNF-a & CRP (87, 88) .
Mild inflammation with IL-8, IL-6, CCL2 (89, 90) .
Neutrophils
Unchanged numbers & impaired killing (78) .
Increased in BALF and lung parenchyma (115) .
Mild increase in BALF (92) .
Macrophages/Monocytes Deficient TLR signaling, less production of pro-inflammatory cytokines (79) (80) (81) .
Increased in airways and lung parenchyma & production of proinflammatory cytokines (115) .
Mild increase in BALF (92) . Higher production of CCL18, IL8, CCL2, S100A9 and MIF (93) .
NK cells Increased numbers of highly differentiated NK cellsless active (74, 75, 79, 83) .
Peripheral blood NK cells are less active and have less phagocytic activity (95) .
DCs
Change phenotype, increase the levels of pro-inflammatory cytokines (85, 86) .
More active in COPD (116) .
T Cells
The proportion of memory cells with CD28null (senescent phenotype) increases and decreases the numbers of naïve T cells (97).
Senescent T cell phenotype and repertoire contraction (100) . Less ability to fight infections.
Increased numbers of senescent T cell phenotype producing Th2 cytokines (101) considered pro-fibrotic.
B Cells
Decreased B cell production and impaired ability to Immunoglobulin classswitch (99) .
B memory cells are more frequent in COPD patients, and have differential class switch recombination (91, 99) .
Extracellular matrix (ECM) changes
Alterations in ECM composition lead to abnormal tissue remodeling (3, 6).
Alterations in ECM composition and TGFβlead to abnormal tissue remodeling (3, 6) . 
